What should you know about biphasic urticaria?

The returning rash may again form raised, itchy welts that move or change shape. The key safety issue is whether symptoms involve only the skin or include breathing difficulty, faintness, vomiting, or swelling of the mouth or throat.

Urticaria develops when chemical mediators released in the skin cause temporary raised welts and itching. “Biphasic” describes the pattern: an initial episode settles, followed by a return of symptoms without a clearly identified new exposure.

Hives can occur alone, while deeper swelling is called angioedema. A biphasic allergic reaction can affect more than the skin, so the return of welts does not by itself show how severe the next phase will be.

Follow the discharge or allergy plan you were given. If an adrenaline auto-injector was prescribed for a serious allergy, use it exactly as instructed when the plan’s emergency criteria are met, then call emergency services. Antihistamines may ease skin symptoms but do not replace adrenaline for anaphylaxis.

Record when each phase began, foods or medicines taken, stings, exercise, infections, and treatments used. Photographing the rash can help because individual welts may fade before an appointment. Do not take extra doses or start corticosteroids unless a clinician has advised a specific regimen.

Call UAE emergency services immediately if hives occur with trouble breathing, wheezing, throat tightness, a hoarse voice, tongue swelling, faintness, confusion, or repeated vomiting. Urgency comes from these warning signs, even if the first phase seemed mild or had resolved.

Seek prompt clinical advice when hives return after treatment, repeatedly recur, leave bruising, remain fixed in one place, or accompany fever or joint pain. These features may require assessment for another cause rather than routine hive care.

Ask whether the episode met criteria for anaphylaxis, how long you should be observed, which medicine treats skin symptoms, and whether you need an adrenaline auto-injector. Clarify what should trigger emergency action if symptoms return and whether allergy follow-up is appropriate.